A 57-year-old man died of sepsis, and an autopsy was performed. Previously, he had undergone percutaneous coronary intervention of the middle left anterior descending coronary artery, with 2 sirolimuseluting stents implanted 61 months before death.
Post-mortem ex-vivo optical coherence tomography (OCT) (LightLab imaging, Westford, Massachusetts), coronary angioscopy (CAS) (FiberTech, Tokyo, Japan) imaging, and pathological examination were performed in the stented segments. OCT (A) A cross-sectional image of optical coherence tomography clearly showed an eccentric intimal growth with the appearance of rapid attenuation of the signals (asterisks) with a diffuse border. The signal-poor area was located inside the stent struts (arrows). In this cross section, the stent struts behind the signal-poor mass (6 to 9 o'clock) were completely invisible because of attenuation of the signal, and the thickness of the fibrous cap overlying the signal-poor area was 60 mm by optical coherence tomography image. images showed in-stent eccentric intimal growth of moderate intimal hyperplasia with rapid attenuation of the signals with diffuse border, such as a thin-cap fibroatheroma (TCFA) in native coronary arteries (Fig. 1A) . Corresponding CAS images revealed that stent struts were covered by intensive yellow neointima (Fig. 1B) . Corresponding histopathologic images demonstrated a large, lipid-rich necrotic core covered with a thin fibrous cap infiltrated by lipid-laden macrophages with few smooth muscle cells (Figs. 1C and 1D) .
Discussion
Based on recent pathological study, rupture of a TCFA-like lesion within the neointima has been reported in the long term after stent implantation and has been proposed to be responsible for very late stent thrombosis (1) . To the best of our knowledge, this is the first case of ex-vivo interrogation of in-stent TCFA containing neointima after drug-eluting stent implantation with OCT and CAS by autopsy specimen. On OCT images, the lipid-rich necrotic core appears as a low-signal-intensity mass because of the strong optical absorption and scattering of lipids at light wavelengths around 1,000 nm (2). Therefore, stent struts cannot be visualized by OCT if there is a lipid-rich necrotic core within the neointima. On the other hand, stent struts behind organized fibrin thrombus can be visualized because OCT signals are not attenuated by this material (3). Therefore, it is important to identify the in-stent TCFAlike neointima whether stent struts behind a low-signal-intensity area are "visible" or "invisible."
